Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephan R. Thurau is active.

Publication


Featured researches published by Stephan R. Thurau.


Ophthalmic Research | 1993

Cells of the immune system and their cytokines in epiretinal membranes and in the vitreous of patients with proliferative diabetic retinopathy.

Shibo Tang; Otto F. Scheiffarth; Stephan R. Thurau; Gerhild Wildner

In the present study, we specifically investigated the presence of the main immune cells, namely T helper/inducer lymphocytes, T suppressor/cytotoxic lymphocytes, B lymphocytes and macrophages, for HLA-DR antigen expression and the cytokines IL-1 alpha and IL-2 in epiretinal membranes of proliferative diabetic retinopathy (PDR) using immunohistochemical staining. The levels of the two cytokines (IL-1 alpha and IL-2) in the vitreous were measured by ELISA. The results show that 18 out of the 32 epiretinal specimens reacted positively with monoclonal anti-CD4 (marker for T helper/inducer cell subset) antibody (56%), 21 reacted with monoclonal anti-CD8 (marker for T suppressor/cytotoxic subset) antibody (66%), 15 reacted with monoclonal anti-CD22 (marker for B lymphocytes) antibody (47%), and 25 (78%) were positive for monoclonal anti-macrophage and anti-HLA-DR antibodies. IL-1 alpha and IL-2 were detected in the epiretinal membranes in 8 out of 13 tested cases (62%). However, in the vitreous, IL-1 alpha was detected in only 3 out of 13 cases (70, 75 and 80 pg/ml, respectively), while IL-2 was not detected in any of the vitreous samples. The results clearly demonstrate that immune cells and their cytokines were found in about half of the epiretinal membrane specimens. The invasion of the immunocompetent cells in the membranes seems to be a secondary event. They would not participate in the pathogenesis of PDR, but probably induce unspecific reactions and thus complicate the disease.


European Journal of Immunology | 1994

Cross‐reactivity between an HLA‐B27‐derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease

Gerhild Wildner; Stephan R. Thurau


European Journal of Immunology | 1996

Orally induced, peptide‐specific γ/δ TCR+ cells suppress experimental autoimmune uveitis

Gerhild Wildner; Thomas Hünig; Stephan R. Thurau


European Journal of Immunology | 1995

Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye

Gerhild Wildner; Stephan R. Thurau


International Immunology | 2004

The fate of autoreactive, GFP+ T cells in rat models of uveitis analyzed by intravital fluorescence microscopy and FACS

Stephan R. Thurau; Thorsten R. Mempel; Alexander Flügel; Maria Diedrichs-Möhring; Fritz Krombach; Naoto Kawakami; Gerhild Wildner


Immunology Today | 1997

Database screening for molecular mimicry

Gerhild Wildner; Stephan R. Thurau; Harold Baum; Huw Davies; Mark Peakman


Archive | 1995

Peptides for treatment of autoimmune diseases

Gerhild Wildner; Stephan R. Thurau


Current Immunology Reviews | 2011

Uveitis in Horses, Rats and Man: What Do We Learn from Our Pets?

Cornelia A. Deeg; Gerhild Wildner; Stephan R. Thurau


Archive | 2007

ResearchArticle CRALBP is a Highly Prevalent Autoantigen for Human Autoimmune Uveitis

Cornelia A. Deeg; Albert J. Raith; Barbara Amann; John W. Crabb; Stephan R. Thurau; Stefanie M. Hauck; Marius Ueffing; Gerhild Wildner; Manfred Stangassinger


Archive | 2005

Immunomodulatory Therapy in Uveitis

Stephan R. Thurau; Gerhild Wildner

Collaboration


Dive into the Stephan R. Thurau's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge